Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI

被引:0
|
作者
Su, Min-Ying [1 ]
Baik, Hyun-Man
Yu, Hon J.
Chen, Jeon-hor
Mehta, Rita S.
Nalcioglu, Orhan
机构
[1] Univ Calif Irvine, John Tu & Thomas Yuen Ctr Funct Oncoimaging, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA
关键词
breast cancer; choline; dynamic contrast enhanced MRI; MR spectroscopic imaging; neoadjuvant chemotherapy; and pharmacokinetic parameters;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although an MRI scanner is a single stand-alone modality, different acquisition techniques may be applied to collect structural and functional information, including vascular or angiogenic properties measured by dynamic contrast enhanced MRI (DCE-MRI) and Choline (Cho) metabolism measured by proton MR spectroscopy imaging (MRSI). They may provide complementary information for a better characterization of neoplasm. In this study, we investigated the correlation between Choline measured by MRSI and vascular parameters measured by DCE-MRI in breast cancer. Fourteen patients with histologically proven invasive breast cancer were included. MRSI from a grid of 8 x 8 voxels within a selected slab from each lesion was performed. Each voxel was 1.0 x 1.0 x 1.2 cm(3). Choline signal-to-noise ratio (SNR) was measured from each voxel showing an identifiable Choline peak. Corresponding DCE kinetics was measured from each voxel, and analyzed with a 2-compartmental model to obtain pharmacokinetic parameters K-trans and k(ep). All parameters showed a wide variation within each lesion, and there were no consistent correlations between regional Cho and DCE parameters within the lesion of each individual patient. This finding might be attributed to the heterogeneous nature of breast cancer. The characteristic Cho and DCE-MRI parameters were obtained for each patient by averaging over all Cho-positive voxels. In these 14 patients there was a significant linear correlation between Cho with percent enhancement at 2 min after injection, SE%-2min (r = 0.75, p = 0.002), and pharmacokinetic parameters K-trans (r = 0.74, p = 0.003), and k(ep) (r = 0.76, p = 0.002). The results suggested that overall there is a correlation between Choline metabolism and angiogenesis activity. Since Choline is associated with cell replication and angiogenesis is required to support tumor growth, this might explain the correlation between these two sets of measures among different lesions.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 50 条
  • [21] Contrast-enhanced mammography in comparison with dynamic contrast-enhanced MRI: which modality is appropriate for whom?
    Kamal, Rasha
    Mansour, Sahar
    Farouk, Amr
    Hanafy, Mennatallah
    Elhatw, Ahmed
    Goma, Mohammed Mohammed
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2021, 52 (01)
  • [22] Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer
    Turnbull, Lindsay W.
    NMR IN BIOMEDICINE, 2009, 22 (01) : 28 - 39
  • [23] Diagnosis of Spinal Lesion Using Heuristic and Pharmacokinetic Parameter Measured by Dynamic Contrast-Enhanced MRI
    Lang, Ning
    Yuan, Huishu
    Yu, Hon J.
    Su, Min-Ying
    ACADEMIC RADIOLOGY, 2017, 24 (07) : 867 - 875
  • [24] Dynamic Contrast Enhanced-MRI in Rectal Cancer: Inter- and Intraobserver Reproducibility and the Effect of Slice Selection on Pharmacokinetic Analysis
    Hoetker, Andreas M.
    Schmidtmann, Irene
    Oberholzer, Katja
    Dueber, Christoph
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2014, 40 (03) : 715 - 722
  • [25] Comparison of Model-Free and Model-Based Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Parameters for Predicting Breast Cancers' Response to Neoadjuvant Chemotherapy
    Lv, Guangjie
    Zhou, Yiming
    Zheng, Dandan
    Gao, Jiayin
    Xu, Zhujin
    Jiang, Lei
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2020, 44 (02) : 269 - 274
  • [26] Preoperative Staging in Breast Cancer: Intraindividual Comparison of Unenhanced MRI Combined With Digital Breast Tomosynthesis and Dynamic Contrast Enhanced-MRI
    Rizzo, Veronica
    Moffa, Giuliana
    Kripa, Endi
    Caramanico, Claudia
    Pediconi, Federica
    Galati, Francesca
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] The relationship between parameters measured using intravoxel incoherent motion and dynamic contrast-enhanced MRI in patients with breast cancer undergoing neoadjuvant chemotherapy: a longitudinal cohort study
    Almutlaq, Zyad M.
    Bacon, Sarah E.
    Wilson, Daniel J.
    Sharma, Nisha
    Dondo, Tatendashe
    Buckley, David L.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [28] Analysis of Volumetric Perfusion Quantitative Parameters Using CS-VIBE Breast Dynamic Contrast Enhanced MR Imaging
    Chang, Yun-Woo
    Lee, Eun Ji
    Hwang, Jiyoung
    Nickel, Dominik
    Sung, Jae Kon
    CURRENT MEDICAL IMAGING, 2023, 19 (11) : 1286 - 1294
  • [29] Can contrast-enhanced MR imaging predict survival in breast cancer?
    Boné, B
    Szabó, BK
    Perbeck, LG
    Veress, B
    Aspelin, P
    ACTA RADIOLOGICA, 2003, 44 (04) : 373 - 378
  • [30] The diagnostic performance of dynamic contrast-enhanced MRI and its correlation with subtypes of breast cancer
    Li, Xun
    Fu, Peng
    Jiang, Ming
    Zhang, Jiaming
    Tan, Lun
    Ai, Tao
    Li, Xingrui
    MEDICINE, 2021, 100 (51) : E28109